Your account is currently paused

Combined rating across 10+ review sites! Read what patients are saying on:

Reputation Summary

Daniel Canter, M.D.

Schedule an Appointment with
Daniel Canter, M.D.

2023 Top Doctors Award by Atlanta Magazine
2023 Top Doctors Award by Atlantan

Castle Connolly
Top Doctor

Dr. Daniel Canter grew up in the Washington D.C. area. He graduated from New York University, cum laude, with a BFA in Film and TV Production. He later received his medical degree from George Washington University School of Medicine, graduating as the valedictorian. He completed his residency in urology from the University of Pennsylvania. Following this, Dr. Canter pursued specialized fellowship training in urologic oncology at the Fox Chase Cancer Center.

Dr. Canter has been awarded many professional affiliations and awards during his career. A few examples of his memberships include the Society for Urologic Oncology (SUO) Clinical Trials Consortium, American Urologic Association (AUA), Radiation Oncology Therapy Group (RTOG), and the Bladder Cancer Advocacy Network (BCAN) Think Tank. He has also received multiple honors and awards, including the American College of Surgeons Young Fellow’s Mentorship Program and the Outstanding Scholar in Urology Award from the University of Pennsylvania’s Urology Department.

In addition to these accomplishments, Dr. Canter has been involved in multiple guest editorships, editorial boards, and manuscript reviews. He has also authored or co-authored over 125 peer-reviewed scientific publications and twenty textbook chapters related to urologic oncology.

Dr. Canter will be working from the Midtown and Riverdale Georgia Urology offices where he will specialize in the care of patients with urologic cancers. He will also be leading the Advanced Prostate Cancer team at Georgia Urology, a specific group of urologist experts designed to help patients treat advanced prostate cancer. Furthermore, he will be leading Georgia Urology’s clinical research efforts.

When asked why Dr. Canter wanted to become a physician and why he chose this specialty, he replied, “It felt like a good fit on a number of levels for myself. Working as a urologic oncologist requires a great mix of medical and surgical subspecialty. In addition, most of my patients are longitudinal, and our treatment relationship is over the long-haul. I love being able to fix their problems quickly. Further, I’m not trying to keep patients from getting worse, I can get them better quickly. It’s gratifying for both me and the patient.”

In his spare time, Dr. Canter loves spending time with his wife, two children, and their dog.

Sees Patients in:


What’s new in advanced prostate cancer: PSMA targeting. Northside Hospital.

Expert Commentary, Northside Hospital Cancer Institute Cancer Care News for Summer 2021, Volume 8, Issue 3, pg 3

Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: A Single-Arm, Open-Label, Repeat-Dose Clinical Trial

In September 2021, Dr. Daniel Canter answered questions about prostate cancer for Northside Hospital’s News Center. Read the full Q&A article with Dr. Canter.